Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 1.180
-0.620 (-34.44%)
Jul 25, 2025, 5:35 PM CET
VMware Market Cap
Neovacs has a market cap or net worth of €471.86 thousand as of August 1, 2025.
Market Cap
471.86K
Enterprise Value
266.78K
Revenue
433.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.18
Market Cap Chart
Since November 5, 2024, Neovacs's market cap has increased from 296.00K to 471.86K, an increase of 59.41%. That is a compound annual growth rate of 88.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 471.86K | 212.20% |
| Dec 31, 2024 | 151.14K | -48.94% |
| Nov 5, 2024 | 296.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.12B |
| Sanofi | 104.18B |
| Sartorius Stedim Biotech | 17.31B |
| bioMérieux | 14.71B |
| Eurofins Scientific SE | 11.74B |
| Ipsen | 9.22B |
| ABIVAX Société Anonyme | 4.64B |
| Virbac | 3.00B |